• November 29, 2004 | Legal Times

    Docket Watch: December 2004

    Below are cases coming before the Supreme Court in the coming weeks and the lawyers who will argue them. "Docket Watch" appears at the beginning of each two-week argument cycle when the hig

    1 minute read

  • Clayworth v. Pfizer, Inc.

    Publication Date: 2010-07-12
    Practice Area:
    Industry:
    Date Filed: 2010-07-12
    Court: Ca. Sup. Ct.
    Judge:
    Attorneys: For plaintiff: Attorneys for Appellant: Alioto Law Firm, Joseph M. Alioto, Joseph M. Alioto, Jr., Theresa D. Moore, Angelina Alioto-Grace, Thomas P. Pier; Law Offices of John H. Boone, John H. Boone; Foreman & Brasso, Russell F. Brasso; Law Offices of James M. Dombroski, James M. Dombroski; Law Offices of Jeffery K. Perkins, Jeffrey K. Perkins; Gary D. McCallister & Associates, Gary D. McCallister, Thomas A. Kelliher, Eric I. Unrein and Jaime Goldstein for Plaintiffs and Appellants. Coughlin Stoia Geller Rudman & Robbins, Pamela M. Parker; Schubert Jonckheer Kolbe & Kralowec and Kimberly A. Kralowec for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiffs and Appellants. Zelle Hofmann Voelbel & Mason, Craig C. Corbitt and Henry A. Cirillo for Pharmacists Planning Services, Inc., as Amicus Curiae on behalf of Plaintiffs and Appellants.
    for defendant: Attorneys for Respondent: Filice Brown Eassa & McLeod, Peter A. Strotz, Paul R. Johnson, William E. Steimle; Davis Polk & Wardwell, Ameila Starr, Arthur F. Golden, William J. Fenrich and Daniel J. Schwartz for Defendant and Respondent AstraZeneca LP. Winston & Strawn, Tyler M. Paetkau, Nicole P. Dogwill, James F. Hurst, Susan A. Pipal, Matthew J. Sullivan; Eimer Stahl Klevorn & Solberg, David M. Stahl, J. Cunyon Gordon and Adam Oyenbanji for Defendant and Respondent Abbott Laboratories. Gibson, Dunn & Crutcher, Jeffrey T. Thomas and James N. Knight for Defendant and Respondent Allergan, Inc. Mayer, Brown, Rowe & Maw, Mayer Brown, Donald M. Falk, John Nadolenco, Mack Anderson; Sheppard Mullin Richter & Hampton, Steven O. Kramer, John P. Stigi III; Hogan & Hartson and Joseph H. Young for Defendant and Respondent Amgen, Inc. Covington & Burling, Elizabeth Abigail Brown, Anita F. Stork, Theodore Voorhees, Jr., and Thomas J. Cosgrove for Defendant and Respondent Boehringer Ingelheim Pharmaceuticals, Inc. Sedgwick, Detert, Moran & Arnold, Paul J. Riehle, Matthew A. Fischer; Cravath, Swaine & Moore, Evan R. Chesler, Elizabeth L. Grayer, Jessica Buturla and Jeffrey B. Korn for Defendant and Respondent Bristol-Myers Squibb Company. Reed Smith, Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer Wolff & Donnelly, Gary Hansen, David Graham and Aaron Mills Scott for Defendant and Respondent Eli Lilly & Company. Irell & Manella, Alexander F. Wiles, John C. Keith; Cleary Gottlieb Steen & Hamilton, George S. Cary, Sara D. Schotland and David I. Gelfand for Defendant and Respondent GlaxoSmithKline PLC. Drinker Biddle & Reath, H. Christian L?Orange, Paul H. Saint-Antoine, Mary E. Kohart, David J. Antczak and Joanne C. Lewers for Defendant and Respondent Hoffmann-La Roche Inc. Folger Levin & Kahn, Crowell & Moring, Beatrice Bich-Dao Nguyen, Samuel Ray Miller, Tracy E. Reichmuth, Cecilia C. Ogbu, Steven E. Wilson; Patterson Belknap Webb & Tyler, William Cavanaugh, Jr., and Cecilia B. Loving for Defendants and Respondents Janssen Pharmaceutica Inc., Johnson & Johnson Health Care Systems, Inc., Ortho Biotech, Inc., and Ortho-McNeil Pharmaceutical, Inc. Hughes Hubbard & Reed, Rita M. Haeusler, John M. Townsend, Scott H. Christensen, James A. Graffam; Orrick, Herrington & Sutcliffe, Robert P. Reznick and David Goldstein for Defendant and Respondent Merck Sharp & Dohme Corp. formerly known as Merck & Co., Inc. Kaye Scholer, Aton Arbisser, Bryant S. Delgadillo, Saul P. Morgenstern, Karin E. Garvey; Faegre & Benson, James A. O?Neal and Kim J. Walker for Defendant and Respondent Novartis Pharmaceuticals Corporation. Nossaman, Gunther, Knox & Elliott, Nossaman, Scott DeVries, Katrina June Lee; Dickstein Shapiro, Peter J. Kadzik, Bernard Nash, Maria Colsey Heard, Milton Marquis and Andres Colin for Defendant and Respondent Pfizer Inc. Latham & Watkins, Charles H. Samel, Jennifer A. Carmassi, Margaret M. Zwisler, Steven H. Schulman and Belinda S. Lee for Defendant and Respondent Pharmaceutical Research and Manufacturers of America. Arnold & Porter, Ronald C. Redcay, Douglas L. Wald, Mark R. Merley, Daniel R. Waldman, Anne P. Davis and Ryan Z. Watts for Defendant and Respondent Wyeth.

    Case Number: No. S166435

    Cite as 10 C.D.O.S. 87895JAMES CLAYWORTH et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Def

  • Linde v. Arab Bank, 10-4519-cv(L)

    Publication Date: 2013-01-23
    Practice Area:
    Industry:
    Court: U.S. Court of Appeals, Second Circuit
    Judge: Before: Chin and Carney, CJJ., and Underhill, DJ.**
    Attorneys: For plaintiff: For Plaintiffs-Appellees: Gary M. Osen, Aaron Schlanger, Osen LLC, Oradell, NJ; Mark S. Werbner, Joel Israel, Sayles Werbner, Dallas, TX; Michael E. Elsner, John M. Eubanks, Vincent I. Parrett, Motley Rice LLC, Mount Pleasant, SC; Steven M. Steingard, Stephen H. Schwartz, Neil L. Glazer, Kohn, Swift & Graf, P.C., Philadelphia, PA; James P. Bonner, Stone Bonner & Rocco LLP, New York, NY; David S. Stone, Stone & Magnanini LLP, Short Hills, NJ, on the brief, Peter Raven-Hansen, Osen LLC, Oradell, NJ.
    for defendant: For Defendant-Appellant: Michele L. Odorizzi, Timothy S. Bishop, Jeffrey W. Sarles, Mayer Brown LLP, Chicago, IL; Philip Allen Lacovara, Mayer Brown LLP, New York, NY; Kevin Walsh, Douglas W. Mateyaschuk, II, DLA Piper LLP (U.S.), New York, NY, on the brief, Stephen M. Shapiro, Mayer Brown LLP, Chicago, IL. For The Hashemite Kingdom of Jordan as amicus curiae in support of Defendant-Appellant: Nicole E. Erb, White & Case LLP, New York, NY, on the brief, Christopher M. Curran, White & Case LLP, New York, NY.

    Case Number: 10-4519-cv(L)

    Cite as: Linde v. Arab Bank, 10-4519-cv(L), NYLJ 1202585263076, at *1 (2d Cir., Decided January 18, 2013)Before: Chin and Carney, CJJ., and Underhill

  • March 20, 2006 | Legal Times

    Docket Watch: March 2006

    Cases coming before the Supreme Court in the coming weeks and the lawyers who will argue them. "Docket Watch" appears at the beginning of each two-week argument cycle when the high co

    1 minute read

  • July 3, 2003 | New York Law Journal

    New York's Next Big Thing: Appellate Specialists

    In many New York firms, a litigator is a litigator, whether arguing a case before the Manhattan Supreme Court or the U.S. Supreme Court.The belief that a litigator should be a generali

    1 minute read

  • January 10, 2012 | New York Law Journal

    Circuit Upsets Fraud Conviction of Ex-Mayer Brown Partner

    The conviction of former Mayer Brown partner Joseph P. Collins for helping Refco Inc. executives defraud investors of more than $2 billion was overturned on Jan. 9 by a federal appeals court.

    1 minute read

  • July 12, 2004 | Legal Times

    Courtside: The Chosen Few

    When Carter Phillips rose to argue in the case of Intel Corp. v. Advanced Micro Devices Inc., on April 20, it was his fifth Supreme Court oral argument of the term, but something

    1 minute read

  • February 17, 2009 | Legal Times

    DOJ post that helps pick judges still vacant

    President Barack Obama has yet to announce a nominee to lead the Justice Department's Office of Legal Policy, which plays a key role in the judicial and U.S. attorney selection process

    1 minute read

  • January 26, 2007 | New York Law Journal

    Keeping an Eye On Eyewitness Testimony

    A lawyer whose latest career move has him promoting doubt as to the sanctity of eyewitness evidence was given the name Ezekiel by parents who "weren't particularly religious, but who loved bib

    1 minute read

  • May 23, 2005 | Legal Times

    In Anderson Case, Uneasy Role for Firms

    A handful of law firms face being pulled into the largest tax fraud case in U.S. history. Though none has been accused of wrongdoing, business lawyers who worked with indicted te

    1 minute read